BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22249238)

  • 21. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in Rodent Models of Glaucoma.
    Mead B; Amaral J; Tomarev S
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):702-714. PubMed ID: 29392316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection for glaucoma: Requirements for clinical translation.
    Levin LA; Crowe ME; Quigley HA;
    Exp Eye Res; 2017 Apr; 157():34-37. PubMed ID: 27955999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protecting retinal ganglion cells.
    Khatib TZ; Martin KR
    Eye (Lond); 2017 Feb; 31(2):218-224. PubMed ID: 28085136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Promote Neuroprotection in a Genetic DBA/2J Mouse Model of Glaucoma.
    Mead B; Ahmed Z; Tomarev S
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5473-5480. PubMed ID: 30452601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New conceptual approaches for pharmacological neuroprotection in glaucomatous neuronal degeneration.
    Neufeld AH
    J Glaucoma; 1998 Dec; 7(6):434-8. PubMed ID: 9871868
    [No Abstract]   [Full Text] [Related]  

  • 27. Retinal ganglion cells, glaucoma and neuroprotection.
    Lipton SA
    Prog Brain Res; 2001; 131():712-8. PubMed ID: 11420983
    [No Abstract]   [Full Text] [Related]  

  • 28. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Ramchand K; Lindsley K
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006539. PubMed ID: 20166085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroprotection in glaucoma--delusion, reality or hope?
    Dimovska-Jordanova A
    Prilozi; 2012; 33(2):163-73. PubMed ID: 23425879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Characteristic features of optic nerve ganglion cells and approaches for neuroprotection. From intracellular to capillary processes and therapeutic considerations].
    Funk RH; Schmidt KG
    Ophthalmologe; 2004 Nov; 101(11):1062-70. PubMed ID: 15455253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroprotection for treatment of glaucoma in adults.
    Sena DF; Lindsley K
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD006539. PubMed ID: 28122126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current understanding of neuroprotection in glaucoma.
    Wein FB; Levin LA
    Curr Opin Ophthalmol; 2002 Apr; 13(2):61-7. PubMed ID: 11880717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroprotection in glaucoma.
    Kaushik S; Pandav SS; Ram J
    J Postgrad Med; 2003; 49(1):90-5. PubMed ID: 12865582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel neuroprotectant against retinal ganglion cell damage in a glaucoma model and an optic nerve crush model in the rat.
    Maeda K; Sawada A; Matsubara M; Nakai Y; Hara A; Yamamoto T
    Invest Ophthalmol Vis Sci; 2004 Mar; 45(3):851-6. PubMed ID: 14985301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optic nerve and neuroprotection strategies.
    Osborne NN; Chidlow G; Layton CJ; Wood JP; Casson RJ; Melena J
    Eye (Lond); 2004 Nov; 18(11):1075-84. PubMed ID: 15534592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the optic disc to measure neuroprotection.
    Mikelberg FS
    Can J Ophthalmol; 2007 Jun; 42(3):421-4. PubMed ID: 17508039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The option of neuroprotective therapeutics for glaucoma].
    Xiong S; Xu X
    Zhonghua Yan Ke Za Zhi; 2014 Aug; 50(8):630-3. PubMed ID: 25385383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pay attention to the secondary optic neuropathy and the safe appropriate applications of optic neuroprotection].
    Zhong Y
    Zhonghua Yan Ke Za Zhi; 2016 Dec; 52(12):881-884. PubMed ID: 27998451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy.
    Levin LA
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S98-101. PubMed ID: 10416753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of alpha-2 agonists in neuroprotection.
    Wheeler L; WoldeMussie E; Lai R
    Surv Ophthalmol; 2003 Apr; 48 Suppl 1():S47-51. PubMed ID: 12852434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.